Ultimovacs ASA
(CHIX:ULTIo)
kr
100.2
0 (0%)
Market Cap: 99.78 Mil
Enterprise Value: -67.61 Mil
PE Ratio: 0
PB Ratio: 0.46
GF Score: 30/100 Ultimovacs ASA (CHIX:ULTIo) Transcripts
- Q1 2024 Ultimovacs ASA Earnings Call TranscriptMay 07, 2024kr100.2Earnings
- Q4 2023 Ultimovacs ASA Earnings Presentation TranscriptFeb 14, 2024
- Q3 2023 Ultimovacs ASA Earnings Presentation TranscriptNov 08, 2023
- Ultimovacs ASA to Discuss the NIPU Study Results Call TranscriptOct 31, 2023
- Q2 2023 Ultimovacs ASA Earnings Call TranscriptAug 22, 2023Earnings
- Ultimovacs ASA to Provide Update on Phase II NIPU Trial TranscriptJun 08, 2023
- Q1 2023 Ultimovacs ASA Earnings Call TranscriptMay 10, 2023Earnings
- Q4 2022 Ultimovacs ASA Earnings Presentation TranscriptFeb 16, 2023
- Ultimovacs ASA at Biostock Life Science Fall Summit TranscriptNov 29, 2022
- Q3 2022 Ultimovacs ASA Earnings Presentation TranscriptNov 10, 2022
- Ultimovacs ASA at Redeye Investor AW TranscriptOct 20, 2022
- Q2 2022 Ultimovacs ASA Earnings Presentation TranscriptAug 19, 2022
- Q1 2022 Ultimovacs ASA Earnings Presentation TranscriptMay 12, 2022
- Ultimovacs ASA at ABGSC Investor Days TranscriptMar 08, 2022
- Q4 2021 Ultimovacs ASA Earnings Presentation TranscriptFeb 17, 2022
- Q3 2021 Ultimovacs ASA Earnings Presentation TranscriptNov 11, 2021
- Q4 2020 Ultimovacs ASA Earnings Call TranscriptFeb 17, 2021Earnings
- Q3 2020 Ultimovacs ASA Earnings Call TranscriptNov 12, 2020Earnings
- Q2 2020 Ultimovacs ASA Earnings Call TranscriptAug 21, 2020Earnings
- Q1 2020 Ultimovacs ASA Earnings Call TranscriptMay 14, 2020Earnings
- Q4 2019 Ultimovacs ASA Earnings Call TranscriptFeb 14, 2020Earnings
- 1